Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure

Schwabedal, P. E.; Brügging-Schmitz, G.; Oestreich, Wolfgang; Szathmary, S

doi:10.1097/00004872-198900076-00136

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Suppression of cerebral, myocardial and renal arteriosclerosis by the calcium antagonist flunarizine in hypertensive rats (Skelton model) without reduction of the high blood pressure

Cited by 3 publications

References 0 publications

Suppression of coronary arteriosclerosis and myocardial sclerosis by gallopamil in Skelton-hypertensive rats

Suppression of coronary arteriosclerosis and myocardial sclerosis by gallopamil in Skelton-hypertensive rats

Reduction of mortality in Skelton-hypertensive rats by prophylactic application of the calcium antagonist Flunarizine without suppression of the high blood pressure

Continuing Education Forum. Coronary Artery Disease: A Link Between Hypertension, Diabetes Mellitus, Hyperlipidemia, and Obesity

Contact Info

Product

Resources

About